Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 3U24AI126683-09S1
Nonhuman Primate Reagent Resource
National Institutes of Health
Grant: 5P40OD028116-02
Nonhuman Primate Antibody Resource for Immune Cell Depletion
National Institutes of Health
Grant: 3P51OD011092-55S1
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
National Institutes of Health
Grant: 2U42OD023038-05
Expanded SPF Rhesus Macaque Breeding Colony for AIDS Research
National Institutes of Health
Grant: 1R56AI148295-01A1
A multivalent prophylactic and therapeutic vaccine against EBV infection and EBV-associated malignancies
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
FWCI
1.56
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals